Literature DB >> 30039267

The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.

Ratanapha Phuan-Udom1,2, Nittaya Lektrakul3, Wanruchada Katchamart4.   

Abstract

As rheumatoid arthritis (RA) is an independent risk factor for osteoporotic fractures, the severity of disease activity may correlate with fracture risk. Our objectives were to determine the prevalence of major osteoporotic and hip fractures in patients with RA and to identify the factors related to their 10-year probabilities. This study enrolled 232 patients with RA, aged 40-90 years, who participated in the Siriraj RA Cohort in 2016 and 2017. Demographic data, disease activity scores 28 (DAS28), and health assessment questionnaires (HAQ) were collected. All participants were evaluated for asymptomatic vertebral fractures by thoracolumbar spine radiography. The osteoporotic fracture risks were determined using the fracture risk assessment tool (FRAX). Most subjects were postmenopausal women in their sixth decade; the median disease duration was 12.95 years. Forty-six percent of patients had osteoporotic fractures, and most (87%) were vertebral fractures. Eighty-one patients had asymptomatic vertebral compression fractures. Of those, 57%, 25%, and 18% had low, moderate, and high 10-year probabilities of major osteoporotic fractures, respectively, while 51%, 34%, and 15% had low, moderate, and high 10-year probabilities of hip fractures, respectively. Factors significantly associated with the 10-year probabilities of major osteoporotic and hip fractures were disease duration (p 0.017, 0.009), menopause duration (p < 0.001 both), cumulative disease activity (DAS28; p 0.004, 0.029), and cumulative functional disability (HAQ; p < 0.001 both). Moderate to high 10-year probabilities of major osteoporotic and hip fractures are common in RA. Cumulative disease severity is a high risk for osteoporotic fractures.

Entities:  

Keywords:  10-year probability of fracture; FRAX; Fracture risk assessment; Osteoporosis; Rheumatoid arthritis

Mesh:

Year:  2018        PMID: 30039267     DOI: 10.1007/s10067-018-4218-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

Review 1.  How does one assess early rheumatoid arthritis in daily clinical practice?

Authors:  P L van Riel; H R Schumacher
Journal:  Best Pract Res Clin Rheumatol       Date:  2001-03       Impact factor: 4.098

2.  A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.

Authors:  L Sinigaglia; A Nervetti; Q Mela; G Bianchi; A Del Puente; O Di Munno; B Frediani; F Cantatore; R Pellerito; S Bartolone; G La Montagna; S Adami
Journal:  J Rheumatol       Date:  2000-11       Impact factor: 4.666

3.  Fracture risk assessment and osteoporosis treatment disparities in 3,970 Japanese patients with rheumatoid arthritis.

Authors:  Takefumi Furuya; Takayuki Hosoi; Seiji Saito; Eisuke Inoue; Atsuo Taniguchi; Shigeki Momohara; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2011-04-13       Impact factor: 2.980

4.  Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment.

Authors:  Abdellah El Maghraoui; Asmaa Rezqi; Aziza Mounach; Lahsen Achemlal; Ahmed Bezza; Imad Ghozlani
Journal:  Rheumatology (Oxford)       Date:  2010-03-31       Impact factor: 7.580

Review 5.  FRAX(®) with and without bone mineral density.

Authors:  John A Kanis; Eugene McCloskey; Helena Johansson; Anders Oden; William D Leslie
Journal:  Calcif Tissue Int       Date:  2011-11-06       Impact factor: 4.333

6.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

7.  Evaluation of functional ability of Thai patients with rheumatoid arthritis by the use of a Thai version of the Health Assessment Questionnaire.

Authors:  M Osiri; U Deesomchok; P Tugwell
Journal:  Rheumatology (Oxford)       Date:  2001-05       Impact factor: 7.580

8.  Relationship of focal erosions, bone mineral density, and parathyroid hormone in rheumatoid arthritis.

Authors:  Maurizio Rossini; Gianfilippo Bagnato; Bruno Frediani; Annamaria Iagnocco; Giovanni LA Montagna; Giovanni Minisola; Maurizio Caminiti; Massimo Varenna; Silvano Adami
Journal:  J Rheumatol       Date:  2011-04-01       Impact factor: 4.666

Review 9.  Effects of rheumatoid arthritis on bone.

Authors:  Glenn Haugeberg; Ragnhild E Ørstavik; Tore K Kvien
Journal:  Curr Opin Rheumatol       Date:  2003-07       Impact factor: 5.006

10.  Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey.

Authors:  Nese Olmez Sarikaya; Secil Kapar Yavasi; Gulten Tan; Servet Satiroglu; Arife Hilal Yildiz; Bengi Oz; Ozlem Yoleri; Asuman Memis
Journal:  Clin Rheumatol       Date:  2014-01-29       Impact factor: 2.980

View more
  10 in total

1.  Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort.

Authors:  Katherine D Wysham; Jane Shofer; Gabriella Lui; Laura Trupin; James S Andrews; Dennis M Black; Jonathan Graf; Dolores M Shoback; Patricia P Katz
Journal:  Semin Arthritis Rheum       Date:  2022-01-31       Impact factor: 5.532

Review 2.  Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis.

Authors:  Bernardo D'Onofrio; Michele di Lernia; Ludovico De Stefano; Serena Bugatti; Carlomaurizio Montecucco; Laura Bogliolo
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

3.  Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.

Authors:  Christina Drevinge; Julia M Scheffler; Catalin Koro-Arvidsson; Daniel Sundh; Hans Carlsten; Inger Gjertsson; Catharina Lindholm; Mattias Lorentzon; Anna Rudin; Anna-Karin Hultgård Ekwall; Ulrika Islander
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

Review 4.  Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.

Authors:  Kuang-Hui Yu; Hsin-Hua Chen; Tien-Tsai Cheng; Yeong-Jian Jan; Meng-Yu Weng; Yeong-Jang Lin; Hung-An Chen; Jui-Tseng Cheng; Kuang-Yung Huang; Ko-Jen Li; Yu-Jih Su; Pui-Ying Leong; Wen-Chan Tsai; Joung-Liang Lan; Der-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

5.  Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.

Authors:  C A Nava-Valdivia; J M Ponce-Guarneros; A M Saldaña-Cruz; E G Corona-Sanchez; M Ramirez-Villafaña; E E Perez-Guerrero; J D Murillo-Saich; B Contreras-Haro; M L Vazquez-Villegas; F Gonzalez-Ponce; D Bonilla-Lara; H Jacobo-Cuevas; J D Centeno-Valadez; G Echeverria-Gonzalez; S Cerpa-Cruz; M F Alcaraz-Lopez; E G Cardona-Muñoz; M Salazar-Paramo; L Gonzalez-Lopez; J I Gamez-Nava
Journal:  Biomed Res Int       Date:  2021-08-30       Impact factor: 3.411

6.  Establishment of a preliminary FRAX®-based intervention threshold for rheumatoid arthritis-associated fragility fracture: a 3-year longitudinal, observational, cohort study.

Authors:  Shan-Fu Yu; Ming-Han Chen; Jia-Feng Chen; Yu-Wei Wang; Ying-Chou Chen; Chung-Yuan Hsu; Han-Ming Lai; Wen-Chan Chiu; Chi-Hua Ko; Hsiao-Ru He; Tien-Tsai Cheng
Journal:  Ther Adv Chronic Dis       Date:  2022-02-25       Impact factor: 5.091

7.  Machine Learning Algorithms: Prediction and Feature Selection for Clinical Refracture after Surgically Treated Fragility Fracture.

Authors:  Hirokazu Shimizu; Ken Enda; Tomohiro Shimizu; Yusuke Ishida; Hotaka Ishizu; Koki Ise; Shinya Tanaka; Norimasa Iwasaki
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

8.  The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis.

Authors:  Samaneh Moshayedi; Baharak Tasorian; Amir Almasi-Hashiani
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

Review 9.  Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide.

Authors:  Hennie G Raterman; Willem F Lems
Journal:  Drugs Aging       Date:  2019-12       Impact factor: 3.923

10.  Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.

Authors:  Po-Heng Lin; Shan-Fu Yu; Jia-Feng Chen; Ying-Chou Chen; Han-Ming Lai; Wen-Chan Chiu; Chung-Yuan Hsu; Yu-Wei Wang; Hsiao-Ru He; You-Yin Chen; Chu-Yin Cheng; Tien-Tsai Cheng
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.